HIV prevention drug could reduce cases globally but USAID cuts prevent access, say experts [The Guardian] ↳

Impact FeedImpact Feed Home
Written By The Guardian

Experts at the Aids 2026 conference in Rio de Janeiro warn that lenacapavir will not reach the people who need it most, The Guardian reports. USAID once provided 73% of donor-funded HIV prevention resources globally, and its dismantling has gutted the peer outreach and harm reduction networks that connect high-risk populations to those services.

The Guardian
Previous

Brazil's HIV advocates say they predicted USAID funding cuts: 'We would see the trends' [The Guardian] ↳
Next

Survey shows toll of USAID's closure on former employees and their families [GovExec] ↳